Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study

This open-label multicentre trial evaluated the efficacy and safety of oral dimethyl fumarate (DMF) in patients with moderate-to-severe plaque psoriasis in real-life clinical practice over 52 weeks. Disease severity and improvement were assessed using the psoriasis area severity index (PASI), body s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellacani, Giovanni, Bigi, Laura, Parodi, Aurora, Burlando, Martina, Lanna, Caterina, Campione, Elena, Rongioletti, Franco, Mugheddu, Cristina, Malara, Giovanna, Moretti, Giovanna, Stingeni, Luca, Hansel, Katharina, Micali, Giuseppe, Naldi, Luigi, Pirro, Federico, Peris, Ketty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410272/
https://www.ncbi.nlm.nih.gov/pubmed/36013015
http://dx.doi.org/10.3390/jcm11164778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410272/
https://www.ncbi.nlm.nih.gov/pubmed/36013015
http://dx.doi.org/10.3390/jcm11164778

Ejemplares similares